Adial Pharmaceuticals Correlations

ADIL Stock

USD 0.79 0.00 0.000003%

The current 90-days correlation between Adial Pharmaceuticals and Transcode Therapeutics is -0.03 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adial Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adial Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Adial Pharmaceuticals Correlation With Market

Good diversification

The correlation between Adial Pharmaceuticals and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.

Moving together with Adial Stock

0.62	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.71	OMGA	Omega Therapeutics	Pair Corr
0.67	PEPG	PepGen	Pair Corr

Moving against Adial Stock

0.67	MNPR	Monopar Therapeutics	Pair Corr
0.35	CINGW	Cingulate Warrants	Pair Corr
0.35	NVCT	Nuvectis Pharma	Pair Corr
0.78	CMPX	Compass Therapeutics	Pair Corr
0.77	OPT	Opthea	Pair Corr
0.75	CVKD	Cadrenal Therapeutics,	Pair Corr
0.67	V	Visa Class A	Pair Corr
0.56	TVTX	Travere Therapeutics Earnings Call This Week	Pair Corr
0.56	KTOS	Kratos Defense Security Earnings Call This Week	Pair Corr
0.42	DAN	Dana Inc	Pair Corr
0.37	HSEEF	Hill Street Beverage	Pair Corr
0.35	STRM	Streamline Health	Pair Corr
0.34	NFLX	Netflix	Pair Corr

Related Correlations Analysis

	RNAZ	ADTX	RVPH	ATXI	AMTI	CBIO	ALRN	BPTH	BNTC	HOTH
RNAZ		0.75	-0.64	0.41	0.0	0.0	0.0	-0.31	-0.46	-0.39	RNAZ
ADTX	0.75		-0.54	0.74	0.0	0.0	0.0	-0.18	-0.29	-0.57	ADTX
RVPH	-0.64	-0.54		-0.52	0.0	0.0	0.0	-0.07	0.65	0.3	RVPH
ATXI	0.41	0.74	-0.52		0.0	0.0	0.0	0.21	-0.31	-0.31	ATXI
AMTI	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	AMTI
CBIO	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	CBIO
ALRN	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	ALRN
BPTH	-0.31	-0.18	-0.07	0.21	0.0	0.0	0.0		0.26	-0.03	BPTH
BNTC	-0.46	-0.29	0.65	-0.31	0.0	0.0	0.0	0.26		-0.12	BNTC
HOTH	-0.39	-0.57	0.3	-0.31	0.0	0.0	0.0	-0.03	-0.12		HOTH
	RNAZ	ADTX	RVPH	ATXI	AMTI	CBIO	ALRN	BPTH	BNTC	HOTH

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ADTX	+ 0.75	RNAZ
ATXI	+ 0.74	ADTX
BNTC	+ 0.65	RVPH
ATXI	+ 0.41	RNAZ
HOTH	+ 0.3	RVPH
BNTC	+ 0.26	BPTH

High negative correlations

RVPH	- 0.64	RNAZ
HOTH	- 0.57	ADTX
RVPH	- 0.54	ADTX
ATXI	- 0.52	RVPH
BNTC	- 0.46	RNAZ
HOTH	- 0.39	RNAZ

Risk-Adjusted Indicators

There is a big difference between Adial Stock performing well and Adial Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adial Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RNAZ	8.92	0.19	0.04	0.16	9.33	(12.71)	28.00	(15.49)	75.46
ADTX	5.42	(2.43)	0.00	3.79	0.00	0.00	7.69	(16.13)	35.15
RVPH	6.74	1.33	0.14	0.96	8.51	(7.53)	18.87	(11.88)	71.13
ATXI	3.60	(0.91)	0.00	(0.79)	0.00	0.00	6.36	(7.89)	31.48
AMTI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CBIO	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALRN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
BPTH	6.55	0.35	0.08	0.20	6.19	(9.27)	7.69	(11.22)	137.94
BNTC	3.29	0.28	0.03	(0.30)	3.90	(3.51)	7.89	(6.24)	22.11
HOTH	6.33	1.93	0.29	(0.98)	4.41	(8.98)	5.19	(7.48)	196.04

Adial Pharmaceuticals Corporate Management

Alex Lugovoy	Chief Officer	Profile
Andrew Taubman	Vice Development	Profile
Catherine Fratila	Controller	Profile
MBA MBA	Treasurer CFO	Profile
Lawrence CPA	Controller	Profile
John JD	General Counsel	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC